An epigenetic signature in peripheral blood predicts active ovarian cancer.
BACKGROUND:Recent studies have shown that DNA methylation (DNAm) markers in peripheral blood may hold promise as diagnostic or early detection/risk markers for epithelial cancers. However, to date no study has evaluated the diagnostic and predictive potential of such markers in a large case control...
Main Authors: | Andrew E Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj, Susan J Ramus, Simon A Gayther, Sophia Apostolidou, Allison Jones, Matthias Lechner, Stephan Beck, Ian J Jacobs, Martin Widschwendter |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-12-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2793425?pdf=render |
Similar Items
-
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study.
by: Martin Widschwendter, et al.
Published: (2008-07-01) -
Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
by: Paul M Trembling, et al.
Published: (2017-06-01) -
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
by: Thomas E. Bartlett, et al.
Published: (2016-05-01) -
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar
by: Jatinderpal K. Kalsi, et al.
Published: (2021-01-01) -
Socioeconomic Status and Ovarian Cancer Stage at Diagnosis: A Study Nested Within UKCTOCS
by: Chloe Karpinskyj, et al.
Published: (2020-02-01)